Page last updated: 2024-09-05

sorafenib and sta 9090

sorafenib has been researched along with sta 9090 in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(sta 9090)
Trials
(sta 9090)
Recent Studies (post-2010) (sta 9090)
6,5207305,25113313129

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)sta 9090 (IC50)
Heat shock protein HSP 90-alphaHomo sapiens (human)1.3771
Heat shock protein HSP 90-betaHomo sapiens (human)1.8193
EndoplasminHomo sapiens (human)0.0377
EndoplasminCanis lupus familiaris (dog)0.01
Heat shock protein 75 kDa, mitochondrialHomo sapiens (human)0.0444

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abdel-Reheim, MA; Aboregela, AM; Al-Ameer, AY; Alamri, MMS; Alfaifi, J; Cavalu, S; Hasan, AM; Hashish, AA; Khalid, TBA; Mohammed, OA; Saber, S; Saleh, LA; Senbel, A1

Other Studies

1 other study(ies) available for sorafenib and sta 9090

ArticleYear
Ganetespib (STA-9090) augments sorafenib efficacy via necroptosis induction in hepatocellular carcinoma: Implications from preclinical data for a novel therapeutic approach.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 164

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Neoplasm; Hypoxia; Liver Neoplasms; Mice; Necroptosis; Sorafenib

2023